Prilactone®, the world's first aldosterone antagonist licensed for the treatment of canine heart disease, has been introduced by CEVA Animal Health.
Clinical trials have demonstrated that the product, which contains spironolactone…
Boehringer Ingelheim Vetmedica has re-launched its Vetmedin website: www.vetmedin.co.uk.
Boehringer says the new site has been designed as a resource for veterinary professionals to help educate clients with dogs suffering from congestive heart failure…
Boehringer Ingelheim Vetmedica has increased its range of marketing and educational materials about heart disease and the use of Vetmedin.
The materials include canine heart disease awareness posters for either the waiting room or consult room which feature…
Boehringer Ingelheim Vetmedica has launched Benefortin (benazepril hydrochloride), an ACE inhibitor licensed for the treatment of congestive heart failure (CHF) in dogs. It is also licensed for the treatment of chronic renal insufficiency (CRI) in cats.
Ceva Animal Health has announced the launch of Cardalis for the treatment of canine heart failure caused by degenerative valvular heart disease.
Cardalis contains what the company says is a unique combination of benazepril and spironolactone in one…
According to the company, the new injectable form of Vetmedin provides rapid acting treatment for canine congestive heart failure originating from valvular…
Ceva Animal Health has launched a competition - open to veterinary surgeons and nurses - to support Cardalis (benazepril and spironolactone), its dual-acting treatment for heart failure in dogs.
To enter the competition, which will run till the end…
Alstoe Ltd has launched Tempora, a chewable, flavoured, spironolactone tablet for dogs, indicated for the treatment of congestive heart failure (CHF) arising from mitral valve disease.
Alstoe says Tempora's flavouring technology, tablet shape and two…
Boehringer Ingelheim has announced that Vetmedin Chewable Tablets have been licensed for treating pre-clinical dilated cardiomyopathy (DCM) in Doberman Pinschers1.
Boehringer says DCM is the most common form of cardiomyopathy in dogs and the second most…
Ceva Animal Health has launched Libeo, a new four-way break, palatable furosemide for the management of heart failure in dogs.
According to the company, furosemide - a diuretic - is the most frequently used treatment for the management of heart failure…
Willows, the Solihull-based multidisciplinary referral centre, has announced that it has acquired The Veterinary Cardiorespiratory Centre, the renowned referral service run by Mike Martin MRCVS, RCVS Specialist in Veterinary Cardiology (pictured right…
Ceva Animal Health has launched Amodip, described as the first ever cat-friendly amlodipine licensed for veterinary use for the treatment of hypertension in cats.
Amodip is a chicken-flavoured, two-way break chewable tablet; its 1.25mg tablet size is…
Prilactone Next is replacing the spironolactone…
The research on which the new indication is based is described by Boehringer…
Davies says pulmonic…
Davies says its Cardiac Electrophysiology Laboratory, headed by Pedro Oliveira (pictured…
The new drug represents the fruit of 8 years of product development and…
The clinic will assess cats and dogs under six months old where a heart murmur has been detected…
The company points to research which shows that most dogs and cats whose…
First opinion practices can refer dogs and cats for routine echocardiography…
CardioCare is based on research carried out at the Purina Technology Center which explored how nutrients can…
The referral centre has invested in a new heart and lung machine, and an oxygen cage, and is expected to take its…
Willows says it is currently the only centre…